Fox Chase Cancer Center is a Philadelphia-based cancer center and institutional investor with strategic participation in U.S. life sciences financings, including early-stage radiopharmaceuticals. It is relevant for founders in oncology, biotechnology, pharmaceuticals and broader HealthTech and Life Sciences seeking mission-aligned institutional capital rather than a conventional venture fund.